Sample Request

Global Biopharmaceutical Contract Manufacturings Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

SELECT LICENSE:

Published on 07/23/2020| Code: MAR41115D| Category: Utilities| Total Pages: 105

The Biopharmaceutical Contract Manufacturings market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Biopharmaceutical Contract Manufacturings market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Biopharmaceutical Contract Manufacturings market. The report focuses on well-known providers in the global Biopharmaceutical Contract Manufacturings industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Biopharmaceutical Contract Manufacturings Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Biopharmaceutical Contract Manufacturings market covered in Chapter 4:

Cambrex Corporation
Jubilant Life Sciences Ltd.
Catalent Inc.
Pfizer Centresource
Abbvie Inc.
Patheon Inc.
Boehringer Ingelheim
Lonza
Recipharm AB
Baxter Biopharma Solutions
Famar
Aenova

In Chapter 11 and 13.3, on the basis of types, the Biopharmaceutical Contract Manufacturings market from 2015 to 2026 is primarily split into:

Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development & Manufacturing
Others

In Chapter 12 and 13.4, on the basis of applications, the Biopharmaceutical Contract Manufacturings market from 2015 to 2026 covers:

Oncology
Central Nervous System
Cardiovascular Disorders
Infectious Diseases
Pulmonary Disorders
Metabolic Disorders
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Biopharmaceutical Contract Manufacturings Market Share by Type (2020-2026)

1.5.2 Active Pharmaceutical Ingredient (API) Manufacturing
1.5.3 Finished Dosage Formulation (FDF) Development & Manufacturing
1.5.4 Others
1.6 Market by Application

1.6.1 Global Biopharmaceutical Contract Manufacturings Market Share by Application (2020-2026)

1.6.2 Oncology
1.6.3 Central Nervous System
1.6.4 Cardiovascular Disorders
1.6.5 Infectious Diseases
1.6.6 Pulmonary Disorders
1.6.7 Metabolic Disorders
1.6.8 Others
1.7 Biopharmaceutical Contract Manufacturings Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Biopharmaceutical Contract Manufacturings Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter’s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Biopharmaceutical Contract Manufacturings Market

3.1 Value Chain Status

3.2 Biopharmaceutical Contract Manufacturings Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Biopharmaceutical Contract Manufacturings

3.2.3 Labor Cost of Biopharmaceutical Contract Manufacturings

3.2.3.1 Labor Cost of Biopharmaceutical Contract Manufacturings Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Cambrex Corporation
4.1.1 Cambrex Corporation Basic Information
4.1.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.1.3 Cambrex Corporation Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.1.4 Cambrex Corporation Business Overview
4.2 Jubilant Life Sciences Ltd.
4.2.1 Jubilant Life Sciences Ltd. Basic Information
4.2.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.2.3 Jubilant Life Sciences Ltd. Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.2.4 Jubilant Life Sciences Ltd. Business Overview
4.3 Catalent Inc.
4.3.1 Catalent Inc. Basic Information
4.3.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.3.3 Catalent Inc. Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.3.4 Catalent Inc. Business Overview
4.4 Pfizer Centresource
4.4.1 Pfizer Centresource Basic Information
4.4.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.4.3 Pfizer Centresource Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.4.4 Pfizer Centresource Business Overview
4.5 Abbvie Inc.
4.5.1 Abbvie Inc. Basic Information
4.5.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.5.3 Abbvie Inc. Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.5.4 Abbvie Inc. Business Overview
4.6 Patheon Inc.
4.6.1 Patheon Inc. Basic Information
4.6.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.6.3 Patheon Inc. Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.6.4 Patheon Inc. Business Overview
4.7 Boehringer Ingelheim
4.7.1 Boehringer Ingelheim Basic Information
4.7.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.7.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.7.4 Boehringer Ingelheim Business Overview
4.8 Lonza
4.8.1 Lonza Basic Information
4.8.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.8.3 Lonza Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.8.4 Lonza Business Overview
4.9 Recipharm AB
4.9.1 Recipharm AB Basic Information
4.9.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.9.3 Recipharm AB Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.9.4 Recipharm AB Business Overview
4.10 Baxter Biopharma Solutions
4.10.1 Baxter Biopharma Solutions Basic Information
4.10.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.10.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.10.4 Baxter Biopharma Solutions Business Overview
4.11 Famar
4.11.1 Famar Basic Information
4.11.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.11.3 Famar Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.11.4 Famar Business Overview
4.12 Aenova
4.12.1 Aenova Basic Information
4.12.2 Biopharmaceutical Contract Manufacturings Product Profiles, Application and Specification
4.12.3 Aenova Biopharmaceutical Contract Manufacturings Market Performance (2015-2020)
4.12.4 Aenova Business Overview

5 Global Biopharmaceutical Contract Manufacturings Market Analysis by Regions

5.1 Global Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Regions

5.1.1 Global Biopharmaceutical Contract Manufacturings Sales by Regions (2015-2020)

5.1.2 Global Biopharmaceutical Contract Manufacturings Revenue by Regions (2015-2020)

5.2 North America Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

5.3 Europe Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

5.6 South America Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

6 North America Biopharmaceutical Contract Manufacturings Market Analysis by Countries

6.1 North America Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries

6.1.1 North America Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)

6.1.2 North America Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)

6.1.3 North America Biopharmaceutical Contract Manufacturings Market Under COVID-19

6.2 United States Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

6.2.1 United States Biopharmaceutical Contract Manufacturings Market Under COVID-19

6.3 Canada Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

6.4 Mexico Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

7 Europe Biopharmaceutical Contract Manufacturings Market Analysis by Countries

7.1 Europe Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries

7.1.1 Europe Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)

7.1.2 Europe Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)

7.1.3 Europe Biopharmaceutical Contract Manufacturings Market Under COVID-19

7.2 Germany Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

7.2.1 Germany Biopharmaceutical Contract Manufacturings Market Under COVID-19

7.3 UK Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

7.3.1 UK Biopharmaceutical Contract Manufacturings Market Under COVID-19

7.4 France Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

7.4.1 France Biopharmaceutical Contract Manufacturings Market Under COVID-19

7.5 Italy Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

7.5.1 Italy Biopharmaceutical Contract Manufacturings Market Under COVID-19

7.6 Spain Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

7.6.1 Spain Biopharmaceutical Contract Manufacturings Market Under COVID-19

7.7 Russia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

7.7.1 Russia Biopharmaceutical Contract Manufacturings Market Under COVID-19

8 Asia-Pacific Biopharmaceutical Contract Manufacturings Market Analysis by Countries

8.1 Asia-Pacific Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Biopharmaceutical Contract Manufacturings Market Under COVID-19

8.2 China Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

8.2.1 China Biopharmaceutical Contract Manufacturings Market Under COVID-19

8.3 Japan Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

8.3.1 Japan Biopharmaceutical Contract Manufacturings Market Under COVID-19

8.4 South Korea Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

8.4.1 South Korea Biopharmaceutical Contract Manufacturings Market Under COVID-19

8.5 Australia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

8.6 India Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

8.6.1 India Biopharmaceutical Contract Manufacturings Market Under COVID-19

8.7 Southeast Asia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Biopharmaceutical Contract Manufacturings Market Under COVID-19

9 Middle East and Africa Biopharmaceutical Contract Manufacturings Market Analysis by Countries

9.1 Middle East and Africa Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Biopharmaceutical Contract Manufacturings Market Under COVID-19

9.2 Saudi Arabia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

9.3 UAE Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

9.4 Egypt Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

9.5 Nigeria Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

9.6 South Africa Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

10 South America Biopharmaceutical Contract Manufacturings Market Analysis by Countries

10.1 South America Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries

10.1.1 South America Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)

10.1.2 South America Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)

10.1.3 South America Biopharmaceutical Contract Manufacturings Market Under COVID-19

10.2 Brazil Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

10.2.1 Brazil Biopharmaceutical Contract Manufacturings Market Under COVID-19

10.3 Argentina Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

10.4 Columbia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

10.5 Chile Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)

11 Global Biopharmaceutical Contract Manufacturings Market Segment by Types

11.1 Global Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Biopharmaceutical Contract Manufacturings Sales and Market Share by Types (2015-2020)

11.1.2 Global Biopharmaceutical Contract Manufacturings Revenue and Market Share by Types (2015-2020)

11.2 Active Pharmaceutical Ingredient (API) Manufacturing Sales and Price (2015-2020)
11.3 Finished Dosage Formulation (FDF) Development & Manufacturing Sales and Price (2015-2020)
11.4 Others Sales and Price (2015-2020)

12 Global Biopharmaceutical Contract Manufacturings Market Segment by Applications

12.1 Global Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Biopharmaceutical Contract Manufacturings Sales and Market Share by Applications (2015-2020)

12.1.2 Global Biopharmaceutical Contract Manufacturings Revenue and Market Share by Applications (2015-2020)

12.2 Oncology Sales, Revenue and Growth Rate (2015-2020)
12.3 Central Nervous System Sales, Revenue and Growth Rate (2015-2020)
12.4 Cardiovascular Disorders Sales, Revenue and Growth Rate (2015-2020)
12.5 Infectious Diseases Sales, Revenue and Growth Rate (2015-2020)
12.6 Pulmonary Disorders Sales, Revenue and Growth Rate (2015-2020)
12.7 Metabolic Disorders Sales, Revenue and Growth Rate (2015-2020)
12.8 Others Sales, Revenue and Growth Rate (2015-2020)

13 Biopharmaceutical Contract Manufacturings Market Forecast by Regions (2020-2026)

13.1 Global Biopharmaceutical Contract Manufacturings Sales, Revenue and Growth Rate (2020-2026)

13.2 Biopharmaceutical Contract Manufacturings Market Forecast by Regions (2020-2026)

13.2.1 North America Biopharmaceutical Contract Manufacturings Market Forecast (2020-2026)

13.2.2 Europe Biopharmaceutical Contract Manufacturings Market Forecast (2020-2026)

13.2.3 Asia-Pacific Biopharmaceutical Contract Manufacturings Market Forecast (2020-2026)

13.2.4 Middle East and Africa Biopharmaceutical Contract Manufacturings Market Forecast (2020-2026)

13.2.5 South America Biopharmaceutical Contract Manufacturings Market Forecast (2020-2026)

13.3 Biopharmaceutical Contract Manufacturings Market Forecast by Types (2020-2026)

13.4 Biopharmaceutical Contract Manufacturings Market Forecast by Applications (2020-2026)

13.5 Biopharmaceutical Contract Manufacturings Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005